1. A new promising oncogenic target (p.C382R) for treatment with pemigatinib in patients with cholangiocarcinoma. (September 2022) Authors: Hempel, Louisa; Lapa, Constantin; Dierks, Alexander; Gaumann, Andreas; Scheiber, Josef; Veloso de Oliveira, Julia; Philipp, Patrick; Oyarzun Laura, Cristina; Wesarg, Stefan; Robert, Sebastian; Hempel, Dirk Journal: Therapeutic advances in medical oncology Issue: Volume 14(2022) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Antitumor Activity of Larotrectinib in Esophageal Carcinoma with NTRK Gene Amplification. (23rd April 2020) Authors: Hempel, Dirk; Wieland, Thomas; Solfrank, Beate; Grossmann, Vera; Steinhard, Johanna; Frick, Andrea; Hempel, Louisa; Eberl, Thomas; Gaumann, Andreas Journal: Oncologist Issue: Volume 25:Number 6(2020) Page Start: e881 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Clinical Practice Observation of Trastuzumab in Patients with Human Epidermal Growth Receptor 2‐Positive Metastatic Adenocarcinoma of the Stomach or Gastroesophageal Junction. (4th June 2020) Authors: Al‐Batran, Salah‐Eddin; Moorahrend, Enno; Maintz, Christoph; Goetze, Thorsten O.; Hempel, Dirk; Thuss‐Patience, Peter; Gaillard, Vincent E.; Hegewisch‐Becker, Susanna Journal: Oncologist Issue: Volume 25:Number 8(2020) Page Start: e1181 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Inhibition of PLK1 by capped‐dose volasertib exerts substantial efficacy in MDS and sAML while sparing healthy haematopoiesis. (8th December 2019) Authors: Dill, Veronika; Kauschinger, Johanna; Hauch, Richard T.; Buschhorn, Lars; Odinius, Timo O.; Müller‐Thomas, Catharina; Mishra, Ritu; Kyncl, Michele C.; Schmidt, Burkhard; Prodinger, Peter M.; Hempel, Dirk; Bellos, Frauke; Höllein, Alexander; Kern, Wolfgang; Haferlach, Torsten; Slotta‐Huspenina, Ju... Journal: European journal of haematology Issue: Volume 104:Number 2(2020) Page Start: 125 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. SARS‐CoV‐2 infections in cancer outpatients—Most infected patients are asymptomatic carriers without impact on chemotherapy. (6th October 2020) Authors: Hempel, Louisa; Piehler, Armin; Pfaffl, Michael W.; Molnar, Jakob; Kirchner, Benedikt; Robert, Sebastian; Veloso, Julia; Gandorfer, Beate; Trepotec, Zeljka; Mederle, Stefanie; Keim, Sabine; Milani, Valeria; Ebner, Florian; Schweneker, Katrin; Fleischmann, Bastian; Kleespies, Axel; Scheiber, Josef... Journal: Cancer medicine Issue: Volume 9:Number 21(2020) Page Start: 8020 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗